• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Astrazeneca To Present Cancer Trial Breakthrough At ESMO 2025

    INDPHARMAPOST

    AZ Breaks Ground On $4.5B API Production Facility In Virginia

    FIERCE PHARMA

    Astrazeneca Strikes DTC Deal With Trump Administration

    BIOSPACE

    Astrazeneca To Formalize MFN Agreement With Trump: MSNBC

    FIERCE PHARMA

    Astrazeneca: Building A Transparent Pipeline From The Ground Up

    FIERCE BIOTECH

    Algen Pharma Partners Astrazeneca For AI Drug Discovery

    PR NEWSWIRE

    Turbine Collaborate With Astrazeneca To Rationalize ADC Discovery

    PR NEWSWIRE

    AstraZeneca`s Baxdrostat Meets Goal in High Blood Pressure StudyS

    REUTERS

    AstraZeneca & Daiichi`s Datroway Boosts survival in Breast Cancer

    REUTERS

    AstraZeneca inks $555M Gene-Editing Tech Deal with Algen

    REUTERS

    Big Pharma`s `Brexit` Draws Call For Anticompetition Probe

    FIERCE PHARMA

    ENHERTU Shows iDFS Benefit in High-Risk Early Breast Cancer

    BUSINESSWIRE

    Az, Daiichi`s Enhertu Notches Another Win In Early Breast Cancer

    FIERCE PHARMA

    Astrazeneca Plots NYSE Listing Amid Uk Industry Pullback

    FIERCE PHARMA

    Novartis, Boehringer Debut DTC Programs With Reduced Drug Prices

    FIERCE PHARMA

    Factor Bio Files Complaint Against Cellectis & AstraZeneca

    PR NEWSWIRE

    Astrazeneca Debuts DTC Service With Discounted Farxiga, Airsupra

    FIERCE PHARMA

    Astrazeneca Makes Last-Chance IRA Appeal To Us Supreme Court

    FIERCE PHARMA

    Direct-To-Patient Programs Are On The Rise At Pharmas: Survey

    FIERCE PHARMA

    ENHERTU + Pertuzumab Gets US Priority Review In 1L HER2+ Cancer

    BUSINESSWIRE

    Burning Rock`s Oncoguide Oncoscreen Plus CDX Approved In Japan

    GLOBENEWSWIRE

    SOPHiA, AstraZeneca Expand Cancer Detection Collaboration

    PR NEWSWIRE

    JCR Pharma & Alexion Hit Milestone in Neurodegenerative Program

    PHARMAWEB

    AstraZeneca`s Saphnelo Triumphs in Phase 3 as Self-Injectable

    PRESS RELEASE

    Airsupra US: Significant Risk Reduction in Mild Asthma Patients

    BUSINESSWIRE

    SAPHNELO Self-Admin TULIP-SC Ph 3 Trial Meets Endpoint in Lupus

    BUSINESSWIRE

    AstraZeneca`s Asthma Drug Fails `Smoker`s Lung` Study

    REUTERS

    AstraZeneca`s At-Home FluMist TV Spot Under FDA Scrutiny

    FIERCE PHARMA

    FDA Issues Over 100 Warnings in Ad Crackdown

    RAPS

    AstraZeneca pauses $270 Million Investment in Britain

    REUTERS

    ENHERTU Type II Variation Validated in EU for HER2 Solid Tumors

    BUSINESSWIRE

    YolTech Secures $45M in AstraZeneca-CICC Led Series B Funding

    PR NEWSWIRE

    AstraZeneca India Introduces Eculizumab for aHUS, PNH Treatment

    EXPRESS PHARMA

    AstraZeneca Strengthens Tagrisso`s Position Against J&J Rivalry

    FIERCE PHARMA

    Tagrisso Plus Chemo Shows Longest Survival in EGFR Lung Cancer

    BUSINESSWIRE

    UK Needs to Adjust Investment Evaluation Model, ABPI Says

    FIERCE PHARMA

    AstraZeneca Cancels Indian Manufacturing License

    FIERCE PHARMA

    FibroGen Sells China Branch to AstraZeneca for $220 Million

    GLOBENEWSWIRE

    AstraZeneca Gears up For Baxdrostat FDA Filing After Ph. 3 Win

    FIERCE BIOTECH

    AstraZeneca to Seek Approval for Blood Pressure Drug

    REUTERS

    University of Michigan Seeks Damages Over AZ`s FluMist Sales

    FIERCE PHARMA

    Lilly, AZ Home in On Sites in Virginia for New Plants

    FIERCE PHARMA

    Polaris Pharmacy Becomes Exclusive US Distributor of FluMist

    BUSINESSWIRE

    China Approves FibroGen China Sale to Astra Zeneca

    GLOBENEWSWIRE

    FLUMIST Intranasal Flu Vaccine Now Available for Home Use

    BUSINESSWIRE

    AstraZeneca Starts DTC Home Delivery of FluMist Vaccine

    FIERCE PHARMA

    AZ, Genentech, Merck top oncology HCP promotions: report

    FIERCE PHARMA

    Nectar Lifesciences Unit VI Earns CGMP Certification from SMDC

    EQUITYBILL

    Sophia Genetics, AstraZeneca Expand AI Breast Cancer Collab

    PR NEWSWIRE

    AZ`s Alexion Highlights gMG in Upcoming Awareness Film

    FIERCE PHARMA

    Symbiosis Achieves 1,000th Injectable Drug Batch Milestone

    EXPRESSPHARMA

    Imfinzi Gets Priority Review, Breakthrough Therapy Status in US

    INDPHARMAPOST

    Trixeo Gets Positive EU CHMP Nod as First GWP Inhaled Medicine

    INDPHARMAPOST

    AstraZeneca, Revna Boost Lung Cancer Treatment Access in Ghana

    BUSINESSWIRE

    AstraZeneca H1 and Q2 2025 Results

    BUSINESSWIRE

    AstraZeneca Abandons Lead TCR Therapy in $200M Neogene Purchase

    FIERCE BIOTECH

    Imfinzi Gets US Priority Review for Early-Stage Gastric Cancers

    BUSINESSWIRE

    AstraZeneca`s Rare Immune Disorder Drug Succeeds in Trial

    REUTERS

    AstraZeneca`s Immune Disorder Drug Succeeds in Late-Stage Trial

    REUTERS

    AstraZeneca Launches Tagrisso Lung Cancer TV Ad

    FIERCE PHARMA

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.